Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders Felicia CebanJoshua D. RosenblatRoger S. McIntyre Therapy in Practice 07 August 2021 Pages: 925 - 934
The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond Wolfgang LöscherPavel Klein Review Article Open access 18 June 2021 Pages: 935 - 963
Pharmacotherapy for Seizures in Tuberous Sclerosis Complex Rima NabboutMathieu KuchenbuchPaolo Curatolo Review Article 21 August 2021 Pages: 965 - 983
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis Amit Bar-OrSusan M. O’BrienJeffrey A. Cohen Review Article Open access 09 August 2021 Pages: 985 - 997
Absolute and Dose-Adjusted Serum Concentrations of Clozapine in Patients Switching vs. Maintaining Treatment: An Observational Study of 1979 Patients Lennart KyllesøRobert Løvsletten SmithEspen Molden Original Research Article Open access 20 August 2021 Pages: 999 - 1008
Safety, Patient-Reported Well-Being, and Physician-Reported Assessment of Walking Ability in Patients with Multiple Sclerosis for Prolonged-Release Fampridine Treatment in Routine Clinical Practice: Results of the LIBERATE Study Giovanni CastelnovoOliver GerlachJoep Killestein Original Research Article Open access 28 July 2021 Pages: 1009 - 1022
Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain Juan C. PascualAna Martín-BlancoJoaquim Soler Original Research Article 09 August 2021 Pages: 1023 - 1032
Correction to: The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond Wolfgang LöscherPavel Klein Correction 17 August 2021 Pages: 1033 - 1034
